EYEGATE PHARMACEUTICALS INC's ticker is EYEG and the CUSIP is 30233M107. A total of 20 filers reported holding EYEGATE PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2019 | $4,000 | -20.0% | 16,000 | 0.0% | 0.00% | -100.0% |
Q1 2019 | $5,000 | -44.4% | 16,000 | -20.0% | 0.00% | 0.0% |
Q4 2018 | $9,000 | +50.0% | 20,000 | 0.0% | 0.00% | 0.0% |
Q3 2018 | $6,000 | -45.5% | 20,000 | 0.0% | 0.00% | 0.0% |
Q2 2018 | $11,000 | +37.5% | 20,000 | 0.0% | 0.00% | 0.0% |
Q1 2018 | $8,000 | -61.9% | 20,000 | 0.0% | 0.00% | -66.7% |
Q4 2017 | $21,000 | – | 20,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ARMISTICE CAPITAL, LLC | 16,802,500 | $5,209,000 | 0.31% |
WEDBUSH SECURITIES INC | 20,000 | $6,000 | 0.00% |
US BANCORP \DE\ | 40,650 | $13,000 | 0.00% |
WELLS FARGO & COMPANY/MN | 100 | $0 | 0.00% |
NORTHERN TRUST CORP | 14,553 | $5,000 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
MILLENNIUM MANAGEMENT LLC | 44,270 | $14,000 | 0.00% |
PANAGORA ASSET MANAGEMENT INC | 107,430 | $33,000 | 0.00% |
MORGAN STANLEY | 5,000 | $2,000 | 0.00% |
Invesco Ltd. | 10,323 | $3,000 | 0.00% |